RubrYc Therapeutics
Latest round
- Series A
Last raised
- Aug 2021
Total raised
- $18M
Investors
- 5
About RubrYc Therapeutics
Founded in 2017 and based in California, US, RubrYc Therapeutics, Inc. operates as a biotechnology company that develops molecular therapeutic antibodies using its proprietary machine learning and computational biology technologies.
Who invested in RubrYc Therapeutics
5 investors across 2 rounds
See all investors in RubrYc Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about RubrYc Therapeutics
Who invested in RubrYc Therapeutics?
RubrYc Therapeutics has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has RubrYc Therapeutics raised?
RubrYc Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did RubrYc Therapeutics last raise money?
RubrYc Therapeutics's most recent round on record is a Series A, in Aug 2021.
What does RubrYc Therapeutics do?
Founded in 2017 and based in California, US, RubrYc Therapeutics, Inc.
Where is RubrYc Therapeutics headquartered?
RubrYc Therapeutics is headquartered in San Carlos, US.
Which VCs invest in companies like RubrYc Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at RubrYc Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like RubrYc Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.